Supportingly, Mitsuishi et al. found that silencing the PPP enzymes G6PD or TKT reduced tumor growth in a KEAP1 mutant NSCLC xenograft model in a similar manner to silencing NRF2 [25]. The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.